Patents Assigned to Colorado Seminary, Owner and Operator of University of Denver
  • Patent number: 11957737
    Abstract: Methods of treating or preventing microbial infection in a subject in need of treatment by administering a therapeutically effective amount of ergothioneine, or functional analog, or prodrug, or salt thereof. Ergothioneine may be advantageously administered in conjunction with lactoferrin.
    Type: Grant
    Filed: June 30, 2022
    Date of Patent: April 16, 2024
    Assignees: COLORADO SEMINARY, OWNER AND OPERATOR OF UNIVERSITY OF DENVER, THE REGENTS OF THE UNIVERSITY OF COLORADO
    Inventors: John Repine, Amani Alhalwani
  • Patent number: 11376311
    Abstract: Methods of treating or preventing microbial infection in a subject in need of treatment by administering a therapeutically effective amount of ergothioneine, or functional analog, or prodrug, or salt thereof. Ergothioneine may be advantageously administered in conjunction with lactoferrin.
    Type: Grant
    Filed: November 1, 2018
    Date of Patent: July 5, 2022
    Assignees: COLORADO SEMINARY, OWNER AND OPERATOR OF UNIVERSITY OF DENVER, THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE
    Inventors: John Repine, Amani Alhalwani
  • Publication number: 20170053398
    Abstract: Various arrangements for identifying and grading cancer in tissue samples are presented. A digital image of a stained tissue sample may be acquired. A Shearlet transform may be performed on the digital image of the stained tissue sample. Shearlet coefficients may be calculated based on the performed Shearlet transform of the normalized digital RGB image of the stained tissue sample. A trained neural network may be applied to create a plurality of feature maps using the digital image and Shearlet coefficients, wherein the trained neural network was trained using a plurality of images and Shearlet coefficients of a plurality of digital images. A classifier may be applied to an output of the trained neural network to identify whether cancer is present in the stained tissue sample. A notification may be output that is indicative of a grade of detected cancer in the sample.
    Type: Application
    Filed: August 17, 2016
    Publication date: February 23, 2017
    Applicant: Colorado Seminary, Owner and Operator of University of Denver
    Inventors: Mohammad H. Mahoor, Hadi Rezaeilouyeh, Ali Mollahosseini